The Virus Project
    Facebook Twitter Instagram
    The Virus Project
    • Home
    • Invest in Schools Summit
      • Summary
      • Strategy
      • Agenda
      • Speakers
      • White Papers
      • Register
      • Purchase Tickets
      • COVID Safety
      • Venues  
      • Live Streaming
    • Events
      • Back to School Conference
        • Videos
        • Summary
        • Sponsors
        • Agenda
        • Speakers
      • The Contagion Conference
    • Initiatives
      • Overview
      • University Research Network
      • Impact Investment Network
    • Approaches
      • Testing
      • Containment
      • Therapies
      • Vaccines
    • Resources
      • Research Library
      • COVID Tests Research Report
      • Marketplace
      • Organizations
      • Media Resources
    • About
      • THE VIRUS PROJECT
      • About the Site
      • Virus Project Team
      • Altru Institute
      • Newsletters
      • Open Source Journalism
      • Join
        • Back to School Conference Registration
        • Join to BEAT COVID
        • Invest
    • Log In
    The Virus Project
    You are at:Home»Diagnostics»Category: "Diagnostics Tech"

    Browsing: Diagnostics Tech

    LumiraDx Achieves CE Mark COVID-19 Molecular Test, RNA STAR Complete

    0
    By VP Staff on July 4, 2021 Diagnostics, Diagnostics Tech, Diagnostics Techreport

    As part of LumiraDx’s Fast Lab Solutions, the test enables laboratories to increase throughput of their existing open channel PCR systems to more than 250 tests per hour London, UK- June 30, 2021 – LumiraDx announced today that it has achieved CE Marking for LumiraDx RNA STAR Complete SARS-CoV-2. The test, which was initially granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) in October of 2020 and re-issued in March 2021, is a rapid, nucleic acid amplification method for high sensitivity, high throughput COVID-19 testing. With improved performance claims and access to additional open channel…

    Read More

    X-Prize Winners for COVID Testing Announced

    0
    By VP Staff on March 16, 2021 Diagnostics, Diagnostics Tech, NEWS, Uncategorized

    LOS ANGELES (March 16, 2021) – XPRIZE announced today the five winning teams in the $6M XPRIZE Rapid Covid Testing competition to create high-quality, affordable COVID-19 testing to help society safely reopen and return to everyday activities. Chosen by an independent panel of judges, the grand prize winning solutions are radically affordable compared to what is currently available on the market; and are comparable to commercial offerings at measuring sensitivity, specificity and limit of detection, with a maximum turnaround time of 12 hours from sample to result.  The winning teams are: Reliable LFC, LLC, Antigen Testing, Carlsbad, United States ChromaCode,…

    Read More
    Prem Premsrirut, M.D, PHD, President and CEO

    SalivaClear is to Help People Across the Nation Return to School and Work with a Self-Collection Approach that is Noninvasive and Simple.

    0
    By Theresa on December 7, 2020 Diagnostics Tech, Uncategorized

    Mirimus is the parent company of SalivaClear, a polymerase chain reaction (PCR) testing system with a focus on serving schools and workplaces. The goal of SalivaClear is to help people across the nation return to school and work with a self-collection approach that is noninvasive and simple. Prior to the outbreak of the coronavirus, Mirimus was heavily involved in genome editing technologies, especially in regards to the synergization of RNAi and CRISPR technologies. Mirimus is also considered a world leader in PCR testing, which is seen as the “gold standard” of Covid-19 testing. SalivaClear is centered around three main…

    Read More

    Aptavid Achieves an Accuracy Metric on Rapid COVID-19 Home-Use Test That Beats Other Tests with FDA Emergency Use Authorizati

    0
    By Theresa on December 7, 2020 Diagnostics Tech

    One of the core metrics of accuracy for a COVID-19 test is what’s known as the “limit of detection.” This refers to the lower limit of how many viral copies must be present in a given quantity of a sample in order for the test to detect the presence of COVID-19. (The lower the limit of detection, the more sensitive and therefore better the test.) On November 25th, a third-party lab verified that Aptavid At Home™ (rapid home-use COVID-19 test kit that is in development has reached a limit of detection of 100,000 viral copies per milliliter. This beats the…

    Read More

    Vela Diagnostics Created a Covid-19 Testing System Based on the “Gold Standard” of PCR Amplification

    0
    By Theresa on December 7, 2020 Diagnostics Tech

    Vela Diagnostics is a New Jersey-based company that has created a Covid-19 testing system based on the “gold standard” of PCR amplification. Prior to the outbreak of Covid-19, Vela Diagnostics had established itself as a worldwide supplier of integrated life sciences and diagnostic solutions. The company had already been specializing in PCR technology and Nex-Generation Sequencing. Their philosophy is to focus on easy-to-use, fast, accurate, and cost-effective patient testing solutions.  Vela’s ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 tests for Covid-19 by analyzing nasal and oral swab samples. This approach uses an automated workflow system using the Sentosa™ SX101 instrument, the Sentosa™…

    Read More
    Prahlad Singh, President and CEO

    PerkinElmer has Developed a Number of Standardized Solutions for the Isolation and Detection of Covid-19

    0
    By Theresa on December 7, 2020 Diagnostics Tech

    PerkinElmer is a Massachusetts-based medical company that is currently working on a number of Covid-19 solutions, including testing, therapeutics, and accelerated research.  PerkinElmer is a Massachusetts-based medical company that has developed a number of standardized solutions for the isolation and detection of Covid-19. In addition to testing, PerkinElmer is involved in accelerated virus research and therapeutic drug development. The company is more than 85 years old, and PerkinElmer was involved in the early development of things like atomic absorption spectrophotometers, aerial panoramic camera lenses, and computer-aided chemistry.  Today, PerkinElmer is an industry leader in fields like electronic laboratory notebooks ELNs,…

    Read More

    Mammoth Biosciences has Developed a Fast, Efficient, and Automated Turnkey Workstation Diagnostics Approach for COVID-19

    0
    By Theresa on December 7, 2020 Diagnostics Tech

    Mammoth Biosciences is a San Francisco based company that specializes in CRISPR technology for Covid-19 testing, and has developed a fast, efficient, and automated turnkey workstation diagnostics approach.  Mammoth Biosciences is a San Francisco-based company that uses CRISPR technology to detect the presence of Covid-19. Founded by a Nobel Prize winner, the company is “harnessing the diversity of nature to power the next generation of CRISPR products.” Using a proprietary discovery platform, Mammoth Biosciences can identify novel Cas proteins. Their Covid-19 testing approach is fast, automated, and efficient. Based around a turkey workstation, Mammoth’s CRISPR-based SARS-CoV-2 molecular assay uses automated…

    Read More
    Eric Lander, President and Founding Director

    The Broad Institute Provides Clinics, Nursing Homes, and Schools with Reliable Access to a RT-PCR Assay Covid-19 Testing System. 

    0
    By Theresa on December 6, 2020 Diagnostics Tech

    With strong connections to Harvard and MIT, the Broad Institute provides clinics, nursing homes, and schools with reliable access to a reliable RT-PCR assay Covid-19 testing system.  Launched in 2004 by Harvard and MIT, the Broad Institute is a medical company that specializes in genomic technology, and they have created an RT-PCR assay Covid-19 testing system. This testing approach is targeted at hospitals, schools, and nursing homes. It is not intended for individual testing. The Broad Institute is already partnering with schools, nursing homes, and medical facilities across the municipality of Cambridge to deliver Covdid-19 testing services.  After the outbreak…

    Read More
    Load More
    VIRUS PROJECT UPDATES
    September 13, 2021

    New Approach to K-12 Education. Self-Directed Model to Present at Altru Salon

    June 9, 2021

    Altru Virus Project Summit in DC to Focus on Stronger Schools

    June 8, 2021

    Core Curriculum for Invest in Schools Summit

    January 26, 2021

    How to Reopen Schools and Keep Them Open. A Virus Project White Paper

    September 1, 2020

    University Fellowships. A Global Network of Scientists to Address Big Challenges like COVID

    About

    The global communications platform for those collaborating to beat the Coronavirus.
    INITIATIVES
    • Invest in Schools Summit
    • University Research Consortium
    • Impact Investment Network
    Links

    Editorial Approach

    Submit Stories/Projects

    Contact Us

    Account Login

    Copyright © 2020

    Type above and press Enter to search. Press Esc to cancel.